Dr. Ciezki on Common Advanced Disease Sites in Patients

Video

Jay Ciezki, MD, Department of Radiation Oncology, Cleveland Clinic, discusses an analysis of patients with various malignancies who commonly presented with advanced disease.

Jay Ciezki, MD, Department of Radiation Oncology, Cleveland Clinic, discusses an analysis of patients with various malignancies who commonly presented with advanced disease.

In clinical practice, Ciezki says he has noticed more patients presenting with advanced disease over the last 2 to 3 years. To gain a deeper understanding of this occurrence, Ciezki and other researchers examined a 20-year database of patients and the stage they presented with.

As a result of the query, Ciezki concluded that more patients presented with advanced stage disease in the last 2 to 3 years compared with patient visits from earlier years. The tumor type that was found to be most commonly presented as advanced was prostate cancer. This is interesting, Ciezki says, because prostate cancer is very screenable, treatable, and curable.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,